Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Sanders

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Urology|October 16, 2018
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder CancerElisabeth E Fransen van de Putte, Floris Pos, Barry Doodeman, et al.
British Journal of Cancer|June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Breast Cancer Research : BCR|August 9, 2019
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytesMarcelo Sobral-Leite, Izhar Salomon, Mark Opdam, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
Frontiers in Immunology|January 6, 2022
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial CancerNick van Dijk, Alberto Gil-Jimenez, Karina Silina, et al.
Nature|December 10, 2025
Fasting boosts breast cancer therapy efficacy via glucocorticoid activationNuno Padrão, Tesa M Severson, Sebastian Gregoricchio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2020
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapyLeonora de Boo, Ashley Cimino-Mathews, Yoni Lubeck, et al.
Nature Communications|September 10, 2020
Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasionBianca Cioni, Anniek Zaalberg, Judy R van Beijnum, et al.
Journal for Immunotherapy of Cancer|April 27, 2024
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanomaJudith M Versluis, Stephanie A Blankenstein, Petros Dimitriadis, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Urology|October 16, 2018
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder CancerElisabeth E Fransen van de Putte, Floris Pos, Barry Doodeman, et al.
British Journal of Cancer|June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Breast Cancer Research : BCR|August 9, 2019
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytesMarcelo Sobral-Leite, Izhar Salomon, Mark Opdam, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
Frontiers in Immunology|January 6, 2022
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial CancerNick van Dijk, Alberto Gil-Jimenez, Karina Silina, et al.
Nature|December 10, 2025
Fasting boosts breast cancer therapy efficacy via glucocorticoid activationNuno Padrão, Tesa M Severson, Sebastian Gregoricchio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2020
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapyLeonora de Boo, Ashley Cimino-Mathews, Yoni Lubeck, et al.
Nature Communications|September 10, 2020
Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasionBianca Cioni, Anniek Zaalberg, Judy R van Beijnum, et al.
Journal for Immunotherapy of Cancer|April 27, 2024
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanomaJudith M Versluis, Stephanie A Blankenstein, Petros Dimitriadis, et al.
Pageof 9